HRP20030701A2 - Natural antibodies active against hiv virus - Google Patents

Natural antibodies active against hiv virus

Info

Publication number
HRP20030701A2
HRP20030701A2 HR20030701A HRP20030701A HRP20030701A2 HR P20030701 A2 HRP20030701 A2 HR P20030701A2 HR 20030701 A HR20030701 A HR 20030701A HR P20030701 A HRP20030701 A HR P20030701A HR P20030701 A2 HRP20030701 A2 HR P20030701A2
Authority
HR
Croatia
Prior art keywords
active against
hiv virus
against hiv
natural antibodies
antibodies active
Prior art date
Application number
HR20030701A
Other languages
English (en)
Croatian (hr)
Inventor
Metlas Radmila
Original Assignee
Diapharm Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI20010500 external-priority patent/ITMI20010500A1/it
Priority claimed from IT2001MI002285A external-priority patent/ITMI20012285A1/it
Application filed by Diapharm Limited filed Critical Diapharm Limited
Publication of HRP20030701A2 publication Critical patent/HRP20030701A2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20030701A 2001-03-09 2003-09-02 Natural antibodies active against hiv virus HRP20030701A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20010500 ITMI20010500A1 (it) 2001-03-09 2001-03-09 Auto-anticorpi naturali e il loro uso nella terapia di malattie da virus dell'immunodeficienza umana
IT2001MI002285A ITMI20012285A1 (it) 2001-10-31 2001-10-31 Anticorpi naturali attivi contro il virus hiv
PCT/EP2002/002454 WO2002072637A1 (en) 2001-03-09 2002-03-06 Natural antibodie active against hiv virus

Publications (1)

Publication Number Publication Date
HRP20030701A2 true HRP20030701A2 (en) 2006-06-30

Family

ID=26332768

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030701A HRP20030701A2 (en) 2001-03-09 2003-09-02 Natural antibodies active against hiv virus

Country Status (28)

Country Link
US (2) US20040106771A1 (ru)
EP (1) EP1366080B1 (ru)
JP (1) JP4601252B2 (ru)
KR (1) KR100871455B1 (ru)
CN (1) CN1494554A (ru)
AP (1) AP2003002852A0 (ru)
AT (1) ATE346870T1 (ru)
AU (1) AU2002257620B2 (ru)
BR (1) BR0207931A (ru)
CA (1) CA2440131A1 (ru)
CY (1) CY1108852T1 (ru)
CZ (1) CZ20032418A3 (ru)
DE (1) DE60216422T2 (ru)
DK (1) DK1366080T3 (ru)
EE (1) EE200300377A (ru)
ES (1) ES2278022T3 (ru)
HR (1) HRP20030701A2 (ru)
HU (1) HUP0303423A3 (ru)
IL (2) IL157753A0 (ru)
MX (1) MXPA03007976A (ru)
NO (1) NO20033934L (ru)
PL (1) PL366785A1 (ru)
PT (1) PT1366080E (ru)
RS (1) RS51011B (ru)
RU (1) RU2003125554A (ru)
SI (1) SI1366080T1 (ru)
TN (1) TNSN03066A1 (ru)
WO (1) WO2002072637A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100330102A1 (en) 2009-06-26 2010-12-30 Wezen Biopharmaceuticals Srl A Socio Unico Immunoglobulin preparation for the treatment of hiv-1 infection

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639513A (en) * 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
US5788687A (en) * 1994-02-01 1998-08-04 Caphco, Inc Compositions and devices for controlled release of active ingredients
US5982866A (en) * 1997-04-25 1999-11-09 At&T Corporation Method and apparatus for forwarding caller identification for a credit card or calling card call to an automatic number identification system of a telephone network
DE19815430B4 (de) * 1998-04-07 2005-12-15 T-Mobile Deutschland Gmbh Verfahren zum Verbindungsaufbau von einem Mobilfunknetz zu einer Zielrufnummer eines privaten Kommunikationsnetzes
ES2527915T3 (es) * 1998-06-09 2015-02-02 Csl Behring Ag Producto de inmunoglobulina G (IgG) líquido
WO2000078019A1 (en) * 1999-06-14 2000-12-21 Wilshire Cellular, Inc. Method and apparatus for selectively establishing communication with one of plural devices associated with a single telephone number
US6818247B1 (en) * 2000-03-31 2004-11-16 Advanced Cardiovascular Systems, Inc. Ethylene vinyl alcohol-dimethyl acetamide composition and a method of coating a stent
US6970719B1 (en) * 2000-06-15 2005-11-29 Sprint Spectrum L.P. Private wireless network integrated with public wireless network
US7336668B2 (en) * 2001-09-24 2008-02-26 Christopher Lyle Adams Communication management system with line status notification for key switch emulation
US8040873B2 (en) * 2001-11-07 2011-10-18 Alcatel Lucent Distributed integration of legacy PBX system with SIP networks
US20030105799A1 (en) * 2001-12-03 2003-06-05 Avaz Networks, Inc. Distributed processing architecture with scalable processing layers
US7546143B2 (en) * 2001-12-18 2009-06-09 Fuji Xerox Co., Ltd. Multi-channel quiet calls
US7146163B2 (en) * 2002-10-01 2006-12-05 Isp Operator Corporation Sender-address-based telecommunications operator callback system and method
US20040086093A1 (en) * 2002-10-29 2004-05-06 Schranz Paul Steven VoIP security monitoring & alarm system
US7904068B2 (en) * 2003-06-06 2011-03-08 At&T Intellectual Property I, L.P. System and method for providing integrated voice and data services utilizing wired cordless access with unlicensed spectrum and wired access with licensed spectrum
US7715413B2 (en) * 2003-10-23 2010-05-11 Emerj, Inc. Multi-network exchange system for telephony applications
ATE527788T1 (de) * 2004-01-14 2011-10-15 Research In Motion Ltd System und verfahren zur drahtlosen provisionierung eines mobilkommunikationsgeräts
US8254989B2 (en) * 2004-07-29 2012-08-28 Sprint Spectrum L.P. Method and system for account balance restriction on application of cellular-PBX integration service
CA2550721A1 (en) * 2005-06-22 2006-12-22 Newstep Networks, Inc. Method and system for a communications session join function to facilitate the provision of enhanced communications services
US20070091907A1 (en) * 2005-10-03 2007-04-26 Varad Seshadri Secured media communication across enterprise gateway

Also Published As

Publication number Publication date
RS51011B (sr) 2010-10-31
JP4601252B2 (ja) 2010-12-22
BR0207931A (pt) 2004-03-02
EE200300377A (et) 2003-10-15
DK1366080T3 (da) 2007-03-26
JP2004532198A (ja) 2004-10-21
EP1366080B1 (en) 2006-11-29
CA2440131A1 (en) 2002-09-19
AU2002257620B2 (en) 2007-09-13
DE60216422D1 (de) 2007-01-11
KR20040000401A (ko) 2004-01-03
CN1494554A (zh) 2004-05-05
ES2278022T3 (es) 2007-08-01
MXPA03007976A (es) 2004-10-15
US20070020290A1 (en) 2007-01-25
EP1366080A1 (en) 2003-12-03
NO20033934D0 (no) 2003-09-05
YU70103A (sh) 2006-05-25
WO2002072637A1 (en) 2002-09-19
US20040106771A1 (en) 2004-06-03
ATE346870T1 (de) 2006-12-15
RU2003125554A (ru) 2005-02-10
NO20033934L (no) 2003-11-06
KR100871455B1 (ko) 2008-12-03
HUP0303423A3 (en) 2005-11-28
PT1366080E (pt) 2007-03-30
IL157753A0 (en) 2004-03-28
AP2003002852A0 (en) 2003-09-06
PL366785A1 (en) 2005-02-07
SI1366080T1 (sl) 2007-06-30
CY1108852T1 (el) 2014-07-02
HUP0303423A2 (hu) 2004-01-28
DE60216422T2 (de) 2007-11-29
CZ20032418A3 (cs) 2004-02-18
TNSN03066A1 (en) 2005-12-23
IL157753A (en) 2010-04-29

Similar Documents

Publication Publication Date Title
ATE264914T1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
EA200200724A1 (ru) Вакцина для профилактической или терапевтической иммунизации против вируса иммунодефицита человека (вич)
DK0980203T3 (da) Antimikrobiel forebyggelse og behandling af humant immundeficiensvirus og andre infektiöse sygdomme
ATE295180T1 (de) Zubereitung zur immunisierung gegen den aids- virus
NO20044039L (no) Konjugatorer av terapeutiske eller cytotoksiske midler og biologisk aktive peptider.
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
TR200003113T2 (tr) 3-(amino- veya aminoalkil) piridinon türevleri ve bunların HIV bağımlı hastalıkların tedavisinde kullanılması.
ATE306938T1 (de) Verwendung von cpg als adjuvans für hivimpstoff
NO20020571L (no) Peptider som blokkerer infeksjonsevnen, og fremgangsmåter for anvendelse av disse
ATE401392T1 (de) Subtypabgestimmte inaktivierte vollvirusvakzine zur behandlung von patienten mit hiv-infektion
WO2005089231A3 (en) Enhanced activity of hiv vaccine using a second generation immunomodulatory oligonucleotide
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
DE602005016552D1 (de) Parapocken-viren in kombination mit anderen antiviralen mitteln zur behandlung von hiv/aids
WO2001040473A3 (en) Pseudomonas aeruginosa antigens
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
CY1105629T1 (el) Πολυπεπτιδιο που επαγει αντισωματα εξουδετερωσης του ηιv
HRP20030701A2 (en) Natural antibodies active against hiv virus
DE602006016416D1 (de) Verfahren zur anwendung von ionisierungsstrahlung bei einer hiv-infektionstherapie
DE60229624D1 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion
HUP0100937A2 (hu) Többszörösen elágazó peptidkonstrukciókat tartalmazó liposzómák és alkalmazásuk humán immundeficiencia vírus ellen
ES2195861T3 (es) Uso de (ir,4s)-4-(6-amino-9h-purin-9-il)-2-ciclopenten-1-metanol en vhb.
DK0545991T3 (da) Peptider, der blokerer infektioner med human immundefektvirus, og fremgangsmåder til anvendelse deraf
WO2003006017A3 (en) Use of certain castanospermine esters in the treatment of influenza virus infections
ATE349532T1 (de) Zytotoxisches t-zellepitop des papillomavirus l1- proteins und seine verwendung in diagnostik und therapie
AU2003255866A8 (en) Gp41 epitope and uses thereof for the treatment of hiv infections

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20100903

Year of fee payment: 9

ODBC Application rejected